90 related articles for article (PubMed ID: 38673877)
1. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review.
Shields CL; Dalvin LA; Vichitvejpaisal P; Mazloumi M; Ganguly A; Shields JA
Indian J Ophthalmol; 2019 Dec; 67(12):1959-1963. PubMed ID: 31755428
[TBL] [Abstract][Full Text] [Related]
2. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
[TBL] [Abstract][Full Text] [Related]
3. Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma.
Maaßen T; Vardanyan S; Brosig A; Merz H; Ranjbar M; Kakkassery V; Grisanti S; Tura A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302435
[TBL] [Abstract][Full Text] [Related]
4. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
Mergener S; Siveke JT; Peña-Llopis S
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of two uveal melanoma cell lines derived from tumors with loss of one chromosome 3.
Nareyeck G; Zeschnigk M; Prescher G; Lohmann DR; Anastassiou G
Exp Eye Res; 2006 Oct; 83(4):858-64. PubMed ID: 16750193
[TBL] [Abstract][Full Text] [Related]
6. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
7. Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin.
Brouwer NJ; Konstantinou EK; Gragoudas ES; Marinkovic M; Luyten GPM; Kim IK; Jager MJ; Vavvas DG
Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):3. PubMed ID: 33798262
[TBL] [Abstract][Full Text] [Related]
8. Importance of GLUT Transporters in Disease Diagnosis and Treatment.
Ismail A; Tanasova M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955833
[TBL] [Abstract][Full Text] [Related]
9.
Silva-Rodríguez P; Fernández-Díaz D; Bande M; Pardo M; Loidi L; Blanco-Teijeiro MJ
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804836
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.
Onken MD; Noda SE; Kaltenbronn KM; Frankfater C; Makepeace CM; Fettig N; Piggott KD; Custer PL; Ippolito JE; Blumer KJ
J Biol Chem; 2022 Jan; 298(1):101495. PubMed ID: 34919964
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
12. Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy.
Kozal K; Jóźwiak P; Krześlak A
Cancer Control; 2021; 28():10732748211041243. PubMed ID: 34554006
[TBL] [Abstract][Full Text] [Related]
13. The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer.
Liu C; Jin Y; Fan Z
Front Oncol; 2021; 11():698023. PubMed ID: 34540667
[TBL] [Abstract][Full Text] [Related]
14. More Than Meets the Eye Regarding Cancer Metabolism.
Kubicka A; Matczak K; Łabieniec-Watała M
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502416
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]